Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $82.5000 (17.86%) ($67.5000 - $83.5000) on Thu. Jan. 17, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 22.59% (three month average) | RSI | 84 | Latest Price | $82.5000(17.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 11.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 94.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -11.295% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -11.295% (StdDev 22.59%) | Hourly BBV | 0 () | Intraday Trend | 3.1% | | | |
|
5 Day Moving Average | $71.5(15.38%) | 10 Day Moving Average | $55.03(49.92%) | 20 Day Moving Average | $36.67(124.98%) | To recent high | -10.8% | To recent low | 534.6% | Market Cap | $1.625b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |